{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:05:45Z","timestamp":1787504745516,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010941","name":"University of Vermont","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ajpc.2025.101262","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T16:00:49Z","timestamp":1755878449000},"page":"101262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["State-of-the-art review: The value of leveraging evidence and data (LEAD) in pediatric screening for familial hypercholesterolemia"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2603-6274","authenticated-orcid":false,"given":"Jonathan N","family":"Flyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L","family":"Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2025.101262_bib0001","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101262_bib0002","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0003","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The Agenda for Familial Hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101262_bib0004","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101262_bib0005","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029175","article-title":"Contemporary homozygous Familial hypercholesterolemia in the United States: insights from the CASCADE FH registry","volume":"12","author":"Cuchel","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ajpc.2025.101262_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"JAHA"},{"key":"10.1016\/j.ajpc.2025.101262_bib0008","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hlc.2019.12.002","article-title":"Familial hypercholesterolaemia in 2020","volume":"29","author":"Pang","year":"2020","journal-title":"A Leading Tier 1 Genomic Appl Heart, Lung Circul"},{"key":"10.1016\/j.ajpc.2025.101262_bib0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","article-title":"Mechanisms of disease: genetic causes of familial hypercholesterolemia","volume":"4","author":"Soutar","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.ajpc.2025.101262_bib0011","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/jpm9030032","article-title":"Barriers and facilitators to genetic testing for familial hypercholesterolemia in the United States: a review","volume":"9","author":"Hendricks-Sturrup","year":"2019","journal-title":"JPM"},{"key":"10.1016\/j.ajpc.2025.101262_bib0012","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.39300.616076.55","article-title":"Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis","volume":"335","author":"Wald","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ajpc.2025.101262_bib0013","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(21)01122-3","article-title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"398","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2025.101262_bib0014","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/2047487316676135","article-title":"Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013","volume":"24","author":"Mundal","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0015","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.101262_bib0016","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action","volume":"5","author":"Wilemon","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0017","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.atherosclerosis.2018.08.051","article-title":"Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","volume":"277","author":"Vallejo-Vaz","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101262_bib0018","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1093\/eurheartj\/ehac224","article-title":"Screening in children for familial hypercholesterolaemia: start now","volume":"43","author":"Groselj","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101262_bib0019","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.11.028","article-title":"Reaching detection targets in familial hypercholesterolaemia: comparison of identification strategies","volume":"293","author":"Wald","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ajpc.2025.101262_bib0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1542\/peds.2009-2546","article-title":"Universal versus targeted blood cholesterol screening among youth: the CARDIAC project","volume":"126","author":"Ritchie","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpc.2025.101262_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.936121","article-title":"Early discovery of children with lysosomal acid lipase deficiency with the universal familial hypercholesterolemia screening Program","volume":"13","author":"Sustar","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ajpc.2025.101262_bib0022","first-page":"S213","volume":"128 Suppl 5","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpc.2025.101262_bib0023","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jacl.2020.01.013","article-title":"Pediatric cholesterol screening practices in 9- to 11-year-olds in a large midwestern primary care setting","volume":"14","author":"Allen-Tice","year":"2020","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpeds.2016.12.078","article-title":"Cholesterol screening and treatment practices and preferences: a survey of United States pediatricians","volume":"185","author":"de Ferranti","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpc.2025.101262_bib0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.acap.2017.11.006","article-title":"Universal lipid screening in 9- to 11-year-olds before and after 2011 guidelines","volume":"18","author":"Mihalopoulos","year":"2018","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.ajpc.2025.101262_bib0026","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2013.10.027","article-title":"Implementation of lipid screening guidelines in children by primary pediatric providers","volume":"164","author":"Dixon","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpc.2025.101262_bib0027","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jama.2023.11330","article-title":"Screening for lipid disorders in children and adolescents: US Preventive Services Task Force Recommendation Statement","volume":"330","author":"Preventive Services Task Force","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101262_bib0028","first-page":"Doc04","article-title":"The time is now: achieving FH paediatric screening across Europe - The Prague Declaration","volume":"16","author":"Bedlington","year":"2022","journal-title":"GMS Health Innov Technol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0029","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0030","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1161\/CIR.0000000000000618","article-title":"Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association","volume":"139","author":"de Ferranti","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101262_bib0031","series-title":"Familial hypercholesterolaemia (FH) : report of a second who consultation","year":"1999"},{"key":"10.1016\/j.ajpc.2025.101262_bib0032","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archpedi.153.11.1154","article-title":"How much time is spent on well-child care and vaccinations?","volume":"153","author":"LeBaron","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ajpc.2025.101262_bib0033","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2105\/AJPH.2020.305967","article-title":"Estimation of the time needed to deliver the 2020 USPSTF preventive care recommendations in primary care","volume":"111","author":"Privett","year":"2021","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ajpc.2025.101262_bib0034","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0009922820903043","article-title":"Parental knowledge and attitudes about universal lipid screening among children aged 9 to 11 years","volume":"59","author":"Kern","year":"2020","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.ajpc.2025.101262_bib0035","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1177\/0009922819884403","article-title":"Quality improvement intervention for universal lipid screening in children aged 9 to 11 years","volume":"58","author":"Stipelman","year":"2019","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.ajpc.2025.101262_bib0036","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2025.101262_bib0037","article-title":"Fear of injections and needle phobia among children and adolescents: an overview of psychological, behavioral, and contextual factors","volume":"4","author":"Orenius","year":"2018","journal-title":"SAGE Open Nurs"},{"key":"10.1016\/j.ajpc.2025.101262_bib0038","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jpepsy\/jsu029","article-title":"Systematic review and meta-analysis of distraction and hypnosis for needle-related pain and distress in children and adolescents","volume":"39","author":"Birnie","year":"2014","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0039","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1001\/jama.2019.4984","article-title":"Trends in levels of lipids and apolipoprotein B in US youths aged 6 to 19 years, 1999-2016","volume":"321","author":"Perak","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ajpc.2025.101262_bib0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3399\/bjgp10X483454","article-title":"Near-patient testing in primary care","volume":"60","author":"Khunti","year":"2010","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ajpc.2025.101262_bib0041","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cca.2017.08.019","article-title":"Implementation of point-of-care testing in a general internal medicine practice: a confirmation study","volume":"473","author":"Lewandrowski","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajpc.2025.101262_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.114118","article-title":"Improvement science increases routine lipid screening in general pediatric cardiology","volume":"273","author":"Flyer","year":"2024","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpc.2025.101262_bib0043","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066542","article-title":"Improving preteen lipid screening rates at well-child visits through quality improvement methods","volume":"155","author":"Gardner","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpc.2025.101262_bib0044","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpeds.2017.05.030","article-title":"Improving universal pediatric lipid screening","volume":"188","author":"DeSantes","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpc.2025.101262_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106732","article-title":"Differences in pediatric cholesterol screening rates between family physicians and pediatricians correlate with conflicting guidelines","volume":"153","author":"Peterson","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.ajpc.2025.101262_bib0046","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpeds.2022.08.034","article-title":"Preventive medicine in Pediatric cardiology practice","volume":"253","author":"Hokanson","year":"2023","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpc.2025.101262_bib0047","doi-asserted-by":"crossref","DOI":"10.1097\/00005650-200108002-00002","article-title":"Changing provider behavior: an overview of systematic reviews of interventions","volume":"39","author":"Grimshaw","year":"2001","journal-title":"Med Care"},{"key":"10.1016\/j.ajpc.2025.101262_bib0048","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jamacardio.2019.0649","article-title":"Effect of a multifaceted quality improvement intervention on the prescription of evidence-based treatment in patients at high cardiovascular risk in Brazil: the BRIDGE cardiovascular Prevention Cluster randomized clinical Trial","volume":"4","author":"Machline-Carrion","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0049","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1097\/pq9.0000000000000401","article-title":"Improving compliance with dyslipidemia screening guidelines in a single-center U.S. Outpatient Pediatric Cardiology Clinic","volume":"6","author":"Pradhan","year":"2021","journal-title":"Pediatr Qual Saf"},{"key":"10.1016\/j.ajpc.2025.101262_bib0050","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101262_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.113973","article-title":"Comparison of clinical decision support tools to improve pediatric lipid screening","volume":"269","author":"Goren","year":"2024","journal-title":"J. Pediatr"},{"key":"10.1016\/j.ajpc.2025.101262_bib0052","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jacl.2016.08.001","article-title":"Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study","volume":"10","author":"Safarova","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2025.101262_bib0053","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-019-0101-5","article-title":"Finding missed cases of familial hypercholesterolemia in health systems using machine learning","volume":"2","author":"Banda","year":"2019","journal-title":"Npj Digit Med"},{"key":"10.1016\/j.ajpc.2025.101262_bib0054","article-title":"Familial hypercholesterolemia in the Electronic Medical Records and genomics network: prevalence, penetrance, cardiovascular risk, and outcomes after return of results","volume":"16","author":"Dikilitas","year":"2023","journal-title":"Circ: Genom Precision Med"},{"key":"10.1016\/j.ajpc.2025.101262_bib0055","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1093\/eurheartj\/ehad547","article-title":"Significance of lipids, lipoproteins, and apolipoproteins during the first 14-16 months of life","volume":"44","author":"Taageby Nielsen","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101262_bib0056","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijns8010014","article-title":"Analytical validation of familial hypercholesterolemia biomarkers in dried blood spots","volume":"8","author":"Held","year":"2022","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.ajpc.2025.101262_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.113469","article-title":"Familial hypercholesterolemia biomarker distribution in dried blood spots","volume":"259","author":"Held","year":"2023","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpc.2025.101262_bib0058","doi-asserted-by":"crossref","DOI":"10.1161\/circ.148.suppl_1.15499","article-title":"Abstract 15499: biochemical and genetic newborn screening for familial hypercholesterolemia","volume":"148","author":"Peterson","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101262_bib0059","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5334\/gh.1316","article-title":"It is time to screen for homozygous familial hypercholesterolemia in the United States","volume":"19","author":"Gidding","year":"2024","journal-title":"Glob Heart"},{"key":"10.1016\/j.ajpc.2025.101262_bib0060","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101262_bib0061","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajpc.2025.101262_bib0062","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.106.176158","article-title":"Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee","volume":"114","author":"Lichtenstein","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101262_bib0063","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1161\/CIRCULATIONAHA.105.169251","article-title":"Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association","volume":"112","author":"Gidding","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2025.101262_bib0064","unstructured":"Key principles for newborn screening. EURORDIS-rare diseases Europe n.d. https:\/\/www.eurordis.org\/publications\/key-principles-for-newborn-screening\/ (accessed June 9, 2025."}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266666772500337X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266666772500337X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:35:17Z","timestamp":1772919317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266666772500337X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":63,"alternative-id":["S266666772500337X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101262","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"State-of-the-art review: The value of leveraging evidence and data (LEAD) in pediatric screening for familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101262"}}